<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Gly380Arg mutation in FGFR3 is the genetic cause for <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> (ACH), the most common form of human <z:hpo ids='HP_0003510'>dwarfism</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The mutation has been proposed to increase FGFR3 dimerization, but the dimerization propensities of <z:mp ids='MP_0002169'>wild-type</z:mp> and mutant FGFR3 have not been compared </plain></SENT>
<SENT sid="2" pm="."><plain>Here we use quantitative imaging FRET to characterize the dimerization of <z:mp ids='MP_0002169'>wild-type</z:mp> FGFR3 and the ACH mutant in plasma membrane-derived vesicles from HEK293T cells </plain></SENT>
<SENT sid="3" pm="."><plain>We demonstrate a small, but statistically significant increase in FGFR3 dimerization due to the ACH mutation </plain></SENT>
<SENT sid="4" pm="."><plain>The data are consistent with the idea that the ACH mutation causes a structural change which affects both the stability and the activity of FGFR3 dimers in the absence of ligand </plain></SENT>
</text></document>